Credit Suisse advice for Teva Pharmaceuticals
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| September 07, 2018 | Credit Suisse | Teva Pharmaceuticals | Hold | 23.00 USD | 70.04 % |
Advice details
Zurich - Op 07 sep verlagen de analisten hun advies voor de Amerikaanse pharmaceut Teva Pharmaceuticals (ISIN: US8816242098 / Mnemo: TEVA) van Kopen naar Houden. Het 12-maands koersdoel blijft gehandhaafd op 23.0 USD.
Back
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2024 ValueSpectrum. All Rights Reserved
Developed and maintained by 